Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease.
about
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.Targeting potassium channels in cancerIdentification of beta-2 as a key cell adhesion molecule in PCa cell neurotropic behavior: a novel ex vivo and biophysical approach.Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cellsProbing kinetic drug binding mechanism in voltage-gated sodium ion channel: open state versus inactive state blockers.Membrane potential and cancer progression.Functional properties of ion channels and transporters in tumour vascularization.Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.Ion channels in cancer: future perspectives and clinical potential.Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy.Impact of intracellular ion channels on cancer development and progression.Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs.Ion transport and cancer: from initiation to metastasis.Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cells.Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction.Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps.
P2860
Q33560677-93CFF04B-5235-4B3B-A60D-A40FDFBC246DQ33820817-34D08DF3-4E9E-4DEA-BC39-65DD50B13859Q33937726-84F78134-FFDE-4F54-A4F8-C69676FC578EQ35180664-93E2BB56-C4C4-4F06-A774-D2C4074C5438Q36525395-08B53F6E-7CB9-46C0-9514-7DCD375CF01EQ36782181-DEB1EAD5-001B-405B-87DF-D502CE905C1FQ38123808-DAF4E6DB-3C58-4FF4-B22D-EB425284E371Q38184988-3907388A-5D29-44A6-B00B-60C4AE728D19Q38184989-E114A1EA-A6CA-41B9-A2E9-71EFFEC79E18Q38184990-B8208E5C-BC7F-48FF-8BD5-140B38A617EEQ38757993-C67514F1-CA3B-4F7E-839C-486944A010A8Q38862322-F74E49C0-7BFA-494A-AA67-2877AC7209DBQ38894913-0962A4B2-F713-4B11-809C-54ADE55513ACQ42565455-B1B358B9-7497-4E64-A549-5EB4601109C1Q46886417-E1754F4B-65F5-450C-92CE-372261C61E45Q51093490-4946EC2C-5C9F-4784-A6EE-4A7C00F3E6AFQ52592870-ADD8F93C-A650-4F02-8985-AC1CE1EFB6F7
P2860
Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Persistent current blockers of ...... ontrolling metastatic disease.
@en
type
label
Persistent current blockers of ...... ontrolling metastatic disease.
@en
prefLabel
Persistent current blockers of ...... ontrolling metastatic disease.
@en
P356
P1476
Persistent current blockers of ...... ontrolling metastatic disease.
@en
P2093
Mustafa B A Djamgoz
Rustem Onkal
P356
10.2174/15748928130107
P577
2013-01-01T00:00:00Z